Normal blood clotting values in premature infants
Official title: Normal Hemostasis Values in Premature Infants
Run by University Hospital, Strasbourg, France · NCT07349251 · Data updated 2026-11-12
We will look at past lab tests to see what normal blood clotting values are from birth until 18 months in babies born before 37 weeks.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Months to 18 Months |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | November 24, 2025 |
| Main results expected | November 2031 |
| Study ends | November 24, 2031 |
| Registry record updated | January 16, 2026 |
| Trial ID | NCT07349251 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are infants born before 37 weeks and aged 18 months or younger whose hemostasis samples were sent to the CHU Strasbourg Hematology Laboratory and who do not have known congenital bleeding disorders or liver failure.
✕Probably not a fit
Infants with known congenital hemostasis disorders, existing coagulopathy, hepatocellular insufficiency, or incomplete laboratory records are unlikely to benefit from this reference-range project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This retrospective observational study compiles hemostasis test results from infants born before 37 weeks whose samples were sent to the Hematology Laboratory at Strasbourg University Hospital. Selected coagulation parameters will be collected from birth through 18 months and analyzed by age to define expected ranges. Infants with incomplete data, congenital bleeding disorders, coagulopathy, or hepatocellular insufficiency will be excluded. Results will be compared where possible with reference values from full-term infants to identify differences.
Why it matters
Potential benefit: If successful, the results could give clinicians clearer age-specific clotting reference ranges for preterm infants and help avoid misdiagnosis or unnecessary treatment.
How similar studies have gone: Previous research has described neonatal coagulation patterns, but large retrospective cohorts specifically defining age-related hemostasis ranges in preterm infants through 18 months are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 months or younger for whom a sample was sent to the Hematology Laboratory at Strasbourg University Hospital for measurement of a hemostasis parameter Exclusion Criteria: * Patients with incomplete data * Patients with a congenital hemostasis disorder (hemophilia A or B, von Willebrand disease), a coagulopathy, or hepatocellular insufficiency
Where it's running
-
Laboratoire d'Hématologie - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Agathe HERB, PharmD
- Email: agathe.herb@chru-strasbourg.fr
- Phone: 33 3 88 12 75 53
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Patient-specific biomechanical modeling of incisional hernias with AI and finite element analysis
Researchers will test a personalized computer model of the abdominal wall for adults with incisional hernias using anonymized CT data and AI to see how the hernia shapes relate to tissue mechanics.
-
Menin inhibitors in pediatric relapsed or refractory acute leukemia
This study looks at kids with relapsed or treatment-resistant acute leukemia who have specific genetic changes and are treated with menin inhibitors to see how they fare.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Predictors of Success and Failure of v-NOTES Hysterectomy for Large Uteri
This study looks at which factors predict whether a v-NOTES hysterectomy for large uteri will be completed without needing to switch to another surgical approach.
-
Prehospital end-of-life care: how professionals use a comfort care booklet in Strasbourg
This study tests how emergency crew members in Strasbourg use a comfort care booklet when caring for patients at end of life, and what they think about it.
-
Toxicity of intensive first-line treatment for adult Burkitt lymphoma
This study looks back at adult Burkitt lymphoma patients treated with very aggressive first-line chemotherapy to see how toxic the treatment is and what their long-term outcomes were.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.